Six patients with chronic hepatitis B were investigated for hepatitis B virus (HBV) DNA both in serum and in peripheral blood mononuclear cells (PBMC) by polymerase chain reaction (PCR) before ,during and after interf...Six patients with chronic hepatitis B were investigated for hepatitis B virus (HBV) DNA both in serum and in peripheral blood mononuclear cells (PBMC) by polymerase chain reaction (PCR) before ,during and after interferon alpha (IFN-a)treatment.All patients responded to IFN therapy with remission of serum alanine aminotransferase (ALT).HBV DNA disappeared in serum of 6 and in PBMCs of 5 patients during the treatment with IFN-a. The average elimination period was 5 weeks (range 3-10 weeks) in serum and 15 weeks (range 12-20weeks) in PBMCs. Relapse of serum ALT was seen in one patient with HBV DNA in PBMCs persistently positive during and after treatment with IFN-a. The results showed that clearance of HBV DNA was more difficult in PBMCs than that in serum,and that the persistent appearance of HBV DNA in PBMCs during and after treatment with IFN-a may imply the failure of IFN therapy.展开更多
In order to study the relationship between replicative status and human leucocyte antigens(HLA),HLA class Ⅱ antigen on hepatocyte membrane was analyzed in liver biopsies from 49 pa-tients with chronic hepatitis B vir...In order to study the relationship between replicative status and human leucocyte antigens(HLA),HLA class Ⅱ antigen on hepatocyte membrane was analyzed in liver biopsies from 49 pa-tients with chronic hepatitis B virus infection.The results revealed that expression of HLA classⅡ antigen on hepatocyte membrane was observed in 57% (13/23) of hepatitis B e antigen (HBeAg)positive,only in 15% (4/26) of anti-HBe positive carriers.The display of HLA class Ⅱ antigen onhepatocyte membrane yeas found in 65% (11/17) hepatitis B core antigen (HBcAg) positive and in19% (6/32) HBcAg negative patients with chronic hepatitis B virus infection.There was nosignificant difference in the expression of HLA class Ⅱ antigen on hepatocyte membrane between mi-nor hepatic diseases and active liver diseases.These findings suggested that display of HLA classⅡ antigen on hepatocyte membrane might be associated with viral replication in the chronic hepati-tis B virus carriers.展开更多
To study the distribution and significance of hepatitis C virus (HCV) C33c antigen, and core antigen in human primary intrahepato-cholangiocarcinoma tissues (PIC). Methods: Immunohistochemistry was used to detect HCV ...To study the distribution and significance of hepatitis C virus (HCV) C33c antigen, and core antigen in human primary intrahepato-cholangiocarcinoma tissues (PIC). Methods: Immunohistochemistry was used to detect HCV antigen and HBxAg. Results: HCV C33c antigen was present in the cytoplasm of cancer cells and hepatic cells and HCV core antigen was present mainly in the nuclei of cancerous tissues and in the cytoplasm of pericancerous liver tissues. In cancerous tissues and pericancerous tissues the positive rates of HCV C33c antigen were 60% (21/35) and 100% (21/21 ) respectively; the positive rates of HCV core antigen were 87. 8% (29/ 33 ) and 61. 9% (13/21) respectively; the positive rates of HBxAg were 74. 3% (26/35) and 76. 2% (16/21) respectively; the simultaneously positive rates of C33c and HBxAg were 48. 6% (17/35) and 76. 2% (16/21). Conclusion: Besides hepatitis B virus (HBV) infection, HCV infection may play an important role in the carcinogenesis of PIC.展开更多
Objective: To explore the changes and significance of tumor suppressor gene p53 in primary hepatocellu-lar carcinoma (PHC ) with hepatitis B virus (HBV ) infection. Methods: Tumor tissues and surrounding nontumortissu...Objective: To explore the changes and significance of tumor suppressor gene p53 in primary hepatocellu-lar carcinoma (PHC ) with hepatitis B virus (HBV ) infection. Methods: Tumor tissues and surrounding nontumortissues of sixteen PHC cases were studied by Southern hybridization to detect the state of HBV-DNA in tissues, byimmunohistochemical staining to determine HBsAg, HBxAg and p53 protein, and by PCR directed sequencing toanalyse the point mutation of p53 gene exons 5 to 8. Results: Among the 16 cases. 13 cases were HBV-DNA posi-tive, 10 tumor cases and 13 nontumor tissues cases HBxAg positive, and 9 cases posltive for p53 protein. The se-quencing of p53 gene point mutation was found in 5 cases, only one of which was sited at codon 249 G to T. Con-clusion: The mutation of p53 gene codon 249 is infrequent in HBV related PHC,indicating the accumulation of p53protein in cells may be associated with expression of HBxAg. HBxAg binding to p53 protein and inactivation of p53function play important roles in the development of PHC.展开更多
The specimens of this study were obtained from 110 cases of chronic hepatitis,108cirrhosis and 110 primary hepatic carcinoma(PHC).Formalin-fixed and paraffin-embedded seetions were stained by ABC method forHBxAg,and b...The specimens of this study were obtained from 110 cases of chronic hepatitis,108cirrhosis and 110 primary hepatic carcinoma(PHC).Formalin-fixed and paraffin-embedded seetions were stained by ABC method forHBxAg,and by PAP method for HRsAg and HBcAgOf the 110 cases of chronic hepatitis,72(65.5％)were positive HBxAg in the liver cells,66(60％)were postitive in HBsAg and 35(31.8％)in HBcAg.Among the 108 eases of drrhosis,84(77.8％)revealed to be HBxAg positive in the liver cells,73(67.6％)were demonstrated to beHBsAg-positive and 18(16.7％)were shown to be HBcAg-positive.Among the 110 eases of pri-mary hepatic carcinoma,64(58.2％)showed HBxAg-positive reaction in cancerous tissues.Therates of positive HRsAg and HBcAg in tumor tissues were 15.5％ and 10.9％,respectively.Six-ty-three(78.8％)of 80 cases of the non-cancerous hepatic tissues displayed HBxAg positivenessand the rates of positive HRsAg and HBcAg in the non-tumor tissues were 47(58.8％)and 21(2.6.3％),respectively.The above-mentioned results sugared that the detection rote of HBxAg inchronic hepatitis,cirrhosis and PHC was higher than that of HBsAg and HBcAg.This studydemonstrates a dose relationship between chronic hepatitis,cirrhosis,PHC and chronic persistentinfection of hepatitis B virus(HBV).Persistent chronic HBV infection plays an important role inthe pathogenesis of chronic hepatitis, cirrhosis and PHC.It is possible that the detection ofHBxAg with anti-HBx could be an additional new diagnostic marker for HBV infection.Howev-er,the role of HBxAg in the pathogenesis of chronic liver diseases needs to be furtherinvestigated.展开更多
In order to investigate the relationship between HBV and hepatocellular carcinoma(HCC),hepatitis B virus DNA(HBV DNA),HBxAg and HBcAg were detected in 44 paraffin-embedded samples of HCC tissue(17 cases with cancer-su...In order to investigate the relationship between HBV and hepatocellular carcinoma(HCC),hepatitis B virus DNA(HBV DNA),HBxAg and HBcAg were detected in 44 paraffin-embedded samples of HCC tissue(17 cases with cancer-surrounding hepatic tissues) and 42 case展开更多
We have synthesized a novel formulation of nanoparticulate（NP） alum adjuvant specifically in the cationic water-in-oil microemulsions of water/benzalkonium bromide（BB）, octyl alcohol/cyclohexane at 30 ℃, which wa...We have synthesized a novel formulation of nanoparticulate（NP） alum adjuvant specifically in the cationic water-in-oil microemulsions of water/benzalkonium bromide（BB）, octyl alcohol/cyclohexane at 30 ℃, which was characterized to be crystalline Al（OH）3 with average particle diameter about 70 nm by the analysis of X-ray diffraction and to have a spherical shape structure by TEM photography analysis. Then adsorption degree was assayed. The OD492 of the NP is about 10 times higher than the bulk（BK） alum adjuvant. Compared to bulk alum adjuvant, we studied the immune effect of the NP alum adjuvant with HBsAg vaccine, which was injected intraperitoneally into Guinea pig, and serum antibody titers of the first and second week after immunization were higher in NP group than BK group by ELISA（P<0\^01, P<0\^05）; Groin immuno-injection intraperitoneally into Balb/c mice, was performed once or there times, prolife responses of spleen cells were determined by （）3H thymidine incorporation; non-specific phagocytosis of macrophage of abdominal cavity was measured by lack of color Malachite Green and IL-2 was assayed by activation mouse spleen cells. It is indicated that all cellular immunity bioassay results were higher in NP group than in BK group, except non-specific phagocytosis of macrophage of abdominal cavity by there times immunity. However, there was no significant differerces. Thus, nanoparticulate alum adjuvant can be employed as a more effective adjuvant for HBsAg vaccine than bulk alum adjuvant in the earlier period of post-immunity.展开更多
文摘Six patients with chronic hepatitis B were investigated for hepatitis B virus (HBV) DNA both in serum and in peripheral blood mononuclear cells (PBMC) by polymerase chain reaction (PCR) before ,during and after interferon alpha (IFN-a)treatment.All patients responded to IFN therapy with remission of serum alanine aminotransferase (ALT).HBV DNA disappeared in serum of 6 and in PBMCs of 5 patients during the treatment with IFN-a. The average elimination period was 5 weeks (range 3-10 weeks) in serum and 15 weeks (range 12-20weeks) in PBMCs. Relapse of serum ALT was seen in one patient with HBV DNA in PBMCs persistently positive during and after treatment with IFN-a. The results showed that clearance of HBV DNA was more difficult in PBMCs than that in serum,and that the persistent appearance of HBV DNA in PBMCs during and after treatment with IFN-a may imply the failure of IFN therapy.
文摘In order to study the relationship between replicative status and human leucocyte antigens(HLA),HLA class Ⅱ antigen on hepatocyte membrane was analyzed in liver biopsies from 49 pa-tients with chronic hepatitis B virus infection.The results revealed that expression of HLA classⅡ antigen on hepatocyte membrane was observed in 57% (13/23) of hepatitis B e antigen (HBeAg)positive,only in 15% (4/26) of anti-HBe positive carriers.The display of HLA class Ⅱ antigen onhepatocyte membrane yeas found in 65% (11/17) hepatitis B core antigen (HBcAg) positive and in19% (6/32) HBcAg negative patients with chronic hepatitis B virus infection.There was nosignificant difference in the expression of HLA class Ⅱ antigen on hepatocyte membrane between mi-nor hepatic diseases and active liver diseases.These findings suggested that display of HLA classⅡ antigen on hepatocyte membrane might be associated with viral replication in the chronic hepati-tis B virus carriers.
文摘To study the distribution and significance of hepatitis C virus (HCV) C33c antigen, and core antigen in human primary intrahepato-cholangiocarcinoma tissues (PIC). Methods: Immunohistochemistry was used to detect HCV antigen and HBxAg. Results: HCV C33c antigen was present in the cytoplasm of cancer cells and hepatic cells and HCV core antigen was present mainly in the nuclei of cancerous tissues and in the cytoplasm of pericancerous liver tissues. In cancerous tissues and pericancerous tissues the positive rates of HCV C33c antigen were 60% (21/35) and 100% (21/21 ) respectively; the positive rates of HCV core antigen were 87. 8% (29/ 33 ) and 61. 9% (13/21) respectively; the positive rates of HBxAg were 74. 3% (26/35) and 76. 2% (16/21) respectively; the simultaneously positive rates of C33c and HBxAg were 48. 6% (17/35) and 76. 2% (16/21). Conclusion: Besides hepatitis B virus (HBV) infection, HCV infection may play an important role in the carcinogenesis of PIC.
文摘Objective: To explore the changes and significance of tumor suppressor gene p53 in primary hepatocellu-lar carcinoma (PHC ) with hepatitis B virus (HBV ) infection. Methods: Tumor tissues and surrounding nontumortissues of sixteen PHC cases were studied by Southern hybridization to detect the state of HBV-DNA in tissues, byimmunohistochemical staining to determine HBsAg, HBxAg and p53 protein, and by PCR directed sequencing toanalyse the point mutation of p53 gene exons 5 to 8. Results: Among the 16 cases. 13 cases were HBV-DNA posi-tive, 10 tumor cases and 13 nontumor tissues cases HBxAg positive, and 9 cases posltive for p53 protein. The se-quencing of p53 gene point mutation was found in 5 cases, only one of which was sited at codon 249 G to T. Con-clusion: The mutation of p53 gene codon 249 is infrequent in HBV related PHC,indicating the accumulation of p53protein in cells may be associated with expression of HBxAg. HBxAg binding to p53 protein and inactivation of p53function play important roles in the development of PHC.
文摘The specimens of this study were obtained from 110 cases of chronic hepatitis,108cirrhosis and 110 primary hepatic carcinoma(PHC).Formalin-fixed and paraffin-embedded seetions were stained by ABC method forHBxAg,and by PAP method for HRsAg and HBcAgOf the 110 cases of chronic hepatitis,72(65.5％)were positive HBxAg in the liver cells,66(60％)were postitive in HBsAg and 35(31.8％)in HBcAg.Among the 108 eases of drrhosis,84(77.8％)revealed to be HBxAg positive in the liver cells,73(67.6％)were demonstrated to beHBsAg-positive and 18(16.7％)were shown to be HBcAg-positive.Among the 110 eases of pri-mary hepatic carcinoma,64(58.2％)showed HBxAg-positive reaction in cancerous tissues.Therates of positive HRsAg and HBcAg in tumor tissues were 15.5％ and 10.9％,respectively.Six-ty-three(78.8％)of 80 cases of the non-cancerous hepatic tissues displayed HBxAg positivenessand the rates of positive HRsAg and HBcAg in the non-tumor tissues were 47(58.8％)and 21(2.6.3％),respectively.The above-mentioned results sugared that the detection rote of HBxAg inchronic hepatitis,cirrhosis and PHC was higher than that of HBsAg and HBcAg.This studydemonstrates a dose relationship between chronic hepatitis,cirrhosis,PHC and chronic persistentinfection of hepatitis B virus(HBV).Persistent chronic HBV infection plays an important role inthe pathogenesis of chronic hepatitis, cirrhosis and PHC.It is possible that the detection ofHBxAg with anti-HBx could be an additional new diagnostic marker for HBV infection.Howev-er,the role of HBxAg in the pathogenesis of chronic liver diseases needs to be furtherinvestigated.
文摘In order to investigate the relationship between HBV and hepatocellular carcinoma(HCC),hepatitis B virus DNA(HBV DNA),HBxAg and HBcAg were detected in 44 paraffin-embedded samples of HCC tissue(17 cases with cancer-surrounding hepatic tissues) and 42 case
文摘目的探讨人类白细胞抗原(human leukocyte antigen,HLA)基因多态性与乙型肝炎病毒(HBV)感染的相关性。方法收集云南省昆明市延安医院健康体检者静脉血样本501例,采用酶联免疫吸附试验(ELISA)检测HBV二对半,根据HBV二对半检测结果分为HBV携带组和既往感染组以及健康对照组3组,用序列特异性引物聚合酶链反应(polymerase chain reaction with sequence specific primers,PCR-SSP)基因分型技术检测HLA-A抗原的基因型,将HBV携带组和健康对照组以及HBV既往感染组和健康对照组的HLA-A基因多态性的分布频率进行比较。采用SPSS17.0软件进行数据统计分析。结果健康对照组HLA-A2阳性数占比47.49%,等位基因频率数占比31.29%;健康对照组基因分布频率总体与中华骨髓库发布的中国常见及确认的HLA-A等位基因表一致。HBV携带组HLA-A2阳性数占比63.04%,等位基因频率数占比42.23%,携带者的HLA-A2阳性率和等位基因频率差异有统计学意义(P<0.05);HBV既往感染组HLA-A2阳性数占比56.14%,等位基因频率数占比35.97%,既往感染组的HLA-A2阳性率和等位基因频率差异无统计学意义(P>0.05)。结论HLA-A2基因可能是慢性乙型肝炎HBV携带者的易感基因。
文摘We have synthesized a novel formulation of nanoparticulate（NP） alum adjuvant specifically in the cationic water-in-oil microemulsions of water/benzalkonium bromide（BB）, octyl alcohol/cyclohexane at 30 ℃, which was characterized to be crystalline Al（OH）3 with average particle diameter about 70 nm by the analysis of X-ray diffraction and to have a spherical shape structure by TEM photography analysis. Then adsorption degree was assayed. The OD492 of the NP is about 10 times higher than the bulk（BK） alum adjuvant. Compared to bulk alum adjuvant, we studied the immune effect of the NP alum adjuvant with HBsAg vaccine, which was injected intraperitoneally into Guinea pig, and serum antibody titers of the first and second week after immunization were higher in NP group than BK group by ELISA（P<0\^01, P<0\^05）; Groin immuno-injection intraperitoneally into Balb/c mice, was performed once or there times, prolife responses of spleen cells were determined by （）3H thymidine incorporation; non-specific phagocytosis of macrophage of abdominal cavity was measured by lack of color Malachite Green and IL-2 was assayed by activation mouse spleen cells. It is indicated that all cellular immunity bioassay results were higher in NP group than in BK group, except non-specific phagocytosis of macrophage of abdominal cavity by there times immunity. However, there was no significant differerces. Thus, nanoparticulate alum adjuvant can be employed as a more effective adjuvant for HBsAg vaccine than bulk alum adjuvant in the earlier period of post-immunity.
